コンテンツへスキップ
Merck
  • Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.

Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.

Biochemical and biophysical research communications (2011-06-10)
Shanshan Yu, Bo Gao, Zhijian Duan, Wei Xu, Sidong Xiong
要旨

Increasing evidence suggests that TRIM family proteins may play important roles in the regulation of innate immune signaling pathways. Here we report TRIM22 is involved in the activation of NF-κB. It was found that overexpression of TRIM22 could dose-dependently activate NF-κB as demonstrated by reporter gene assay and electrophoretic mobility shift assay, but had no effect on the activity of other transcription factors, including NF-AT, AP-1, C/EBP and IRFs. Further study showed that both the N-terminal RING domain and C-terminal SPRY domain were crucial for TRIM22-mediated NF-κB activation. Moreover, our results revealed that TRIM22 overexpression could significantly induce the secretion of pro-inflammatory cytokines by human macrophage cell line U937 in an NF-κB-dependent manner. These data suggested that TRIM22 was a positive regulator of NF-κB-mediated transcription.